Response to: Note the distinction between myocarditis, novel coronavirus myocarditis and COVID-19 vaccine-associated myocarditis
QJM
.
2022 Oct 25;115(10):696.
doi: 10.1093/qjmed/hcab281.
Authors
T Awaya
1
,
T Koizumi
1
,
Y Enomoto
1
,
M Moroi
1
,
M Nakamura
1
Affiliation
1
From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
PMID:
34791457
PMCID:
PMC9619480
DOI:
10.1093/qjmed/hcab281
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19*
Humans
Myocarditis* / chemically induced
Myocarditis* / diagnosis
SARS-CoV-2
Substances
COVID-19 Vaccines